News

Targeted Oncology15h

Triplet Therapy Shows Promise for Advanced TNBC Regardless of PD-L1 Status

A novel triple therapy shows promise for advanced triple-negative breast cancer, offering hope for patients with limited ...
TipRanks on MSN16h

Gilead Sciences Stock Surges Amid Promising Trials

Gilead Sciences ( ($GILD) ) has risen by 7.31%. Read on to learn why. Gilead Sciences has seen a notable increase in its ...